Click on a compound for more information.
Therapy Pre Clinical Phase 1 Phase 2 Phase 3 Approved
BTT1023 (timolumab)
 
 
 
 
 
SYN120
 
 
 
 
 
Cimaglermin alfa (GGF2)
 
 
 
 
 
rHlgM22
 
 
 
 
 
*Further development is currently deferred